Skip to content

Strategies for immediate recovery and extubation after general anesthesia: a retrospective cohort study

Strategies for immediate recovery and extubation after general anesthesia: a retrospective cohort study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400080085
Enrollment
Unknown
Registered
2024-01-19
Start date
2024-01-25
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

Experimental group:The strategies for rapid recovery and extubation after general anesthesia include the use of high-dose remifentanil(0.3~0.5µg/kg/min) and reduced anesthetic gas inhalation during op
Control group:Conventional general anesthesia is performed, and only sugammadex sodium is administered at the end of the operation.

Sponsors

Taizhou Hospital of Zhejiang Province
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 95 Years

Inclusion criteria

Inclusion criteria: All patients aged =18 years undergoing noncardiac surgery under general anesthesia at our medical center between July 2023 and December 2023. Rocuronium bromide was used intraoperatively and antagonized by sugammadex sodium at the end of surgery.

Exclusion criteria

Exclusion criteria: ?Patients with preoperative impaired consciousness;?Patients with perioperative cardiorespiratory instability;?Patients undergoing intracranial surgery.

Design outcomes

Primary

MeasureTime frame
5-minute extubation rate in the operating room;

Secondary

MeasureTime frame
Anesthesia recovery time;Stay length in PACU;Extubation time;Postoperative pain score;The incidence of delirium and emergence agitation;The incidence of hypertension and hypotension;The incidence of PACU hypoxemia;Incidence of analgesic administration in the PACU;

Countries

China

Contacts

Public ContactGuang-qiu Zhu

Taizhou Hospital of Zhejiang Province

inchina888999@163.com+86 137 5760 9305

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026